Peking Union Medical College Hospital, Chinese Academy of Medical Sciences
Beijing, Beijing Municipality, 100730, China
NCT Number: NCT02999867
This study is designed to evaluate short term effect of triticale, mung bean and adzuki bean intervention for health improvement in patients with type 2 diabetes.
Looking for future studies?
Notify Me30 year–65 year
All sexes
Interventional
Not applicable
Beijing, Beijing Municipality, 100730, China
The study will evaluate the effect of triticale, mung bean and adzuki bean on metabolic and nutritional status of patients with type 2 diabetes after 30 days of intervention. Patients will be assigned to control or intervention group (A diet including triticale and mung bean; B diet including adzuki bean). Blood and urine samples will be collected at baseline and after 30 days of intervention.
Healthy volunteers accepted: No
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
Exclusion criteria
subjects are assigned to intake of triticale and mung bean for 30 days
Other names: M1 triticale and mung bean
subjects are assigned to intake of adzuki bean for 30 days
Other names: M2 adzuki bean
Time frame: baseline and 30 d
Time frame: baseline and 30 d
Time frame: baseline and 30 d
Time frame: baseline and 30 d
Time frame: baseline and 30 d
Time frame: baseline and 30 d
Time frame: baseline and 30 d
Time frame: baseline and 30 d
Peking Union Medical College Hospital
Other
Effect of Triticale, Mung Bean and Adzuki Bean Intervention on Metabolic and Nutritional Status of Patients With Type 2 Diabetes Mellitus
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT03313752
Diabetes Mellitus, Endocrine System Diseases
Rome, RM, Italy
View Trial DetailsNCT07203677
Arterial Occlusive Diseases, Arteriosclerosis
Boston, Massachusetts, United States
View Trial DetailsNCT05457088
Atrophy, Inflammation
Athens, Attica, Greece
View Trial DetailsNCT00690326
Behavior, Motor Activity
Thiruvananthapuram, Kerala, India
View Trial Details